| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Okt―24 |
A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity |
Toshiya Oba, Daiki Homma, Sophia Jobien M. Limlingan, Aoi Fukuchi, Akiko Asada, Taro Saito, Kanae Ando |
| 2 |
[GO] |
2023―Mai―11 |
Uncovering a neurological protein signature for severe COVID-19 |
Omar El-Agnaf, Ilham Bensmail, Maryam A.Y. Al-Nesf, James Flynn, Mark Taylor, Nour K. Majbour, et al. (+13) Ilham Y. Abdi, Nishant N. Vaikath, Abdulaziz Farooq, Praveen B. Vemulapalli, Frank Schmidt, Khalid Ouararhni, Heba H. Al-Siddiqi, Abdelilah Arredouani, Patrick Wijten, Mohammed Al-Maadheed, Vidya Mohamed-Ali, Julie Decock, Houari B. Abdesselem |
| 3 |
[GO] |
2022―Mrz―30 |
Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection |
Masha G. Savelieff, Eva L. Feldman, Amro M. Stino |
| 4 |
[GO] |
2021―Nov―13 |
SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via spike protein |
Rayan Khaddaj-Mallat, Natija Aldib, Maxime Bernard, Anne-Sophie Paquette, Aymeric Ferreira, Sarah Lecordier, et al. (+3) Armen Saghatelyan, Louis Flamand, Ayman ElAli |
| 5 |
[GO] |
2020―Okt―11 |
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier |
Tetyana P. Buzhdygan, Brandon J. DeOre, Abigail Baldwin-Leclair, Trent A. Bullock, Hannah M. McGary, Jana A. Khan, et al. (+6) Roshanak Razmpour, Jonathan F. Hale, Peter A. Galie, Raghava Potula, Allison M. Andrews, Servio H. Ramirez |
| 6 |
[GO] |
2020―Jul―02 |
Neurobiology of coronaviruses: Potential relevance for COVID-19 |
Mauro Cataldi, Giuseppe Pignataro, Maurizio Taglialatela |
|
